Reify Health
Total Raised
$483.64MInvestors Count
11Deal Terms
3Funding, Valuation & Revenue
9 Fundings
Reify Health has raised $483.64M over 9 rounds.
Reify Health's latest funding round was a Series D for $220M on April 21, 2022.
Reify Health's valuation in August 2021 was $2,200M.
Reify Health's latest post-money valuation is from April 2022.
Sign up for a free demo to see Reify Health's valuations in April 2022 and more.
Date | Round | Amount | Investors | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Revenue | Sources |
---|---|---|---|---|---|---|
4/21/2022 | Series D | $220M | 5 | |||
8/10/2021 | Series C | $2,200M | ||||
8/12/2020 | Series B | |||||
12/24/2018 | Series A - II | |||||
1/1/2018 | Series A |
Date | 4/21/2022 | 8/10/2021 | 8/12/2020 | 12/24/2018 | 1/1/2018 |
---|---|---|---|---|---|
Round | Series D | Series C | Series B | Series A - II | Series A |
Amount | $220M | ||||
Investors | |||||
Valuation | $2,200M | ||||
Revenue | |||||
Sources | 5 |
Reify Health Deal Terms
3 Deal Terms
Reify Health's deal structure is available for 3 funding rounds, including their Series D from April 21, 2022.
Round | Series D | Series C | Convertible Note |
---|---|---|---|
Funding Date | |||
Pre-Money Valuation | |||
Post-Money Valuation | |||
Amount Raised | |||
Shares Authorized | |||
Issuance Price | |||
Dividend Rate | |||
Liquidation Preferences | |||
Liquidation Price | |||
Participation | |||
Conversion Price | |||
Anti Dilution | |||
General Voting | |||
Board Voting | |||
Par Value |
Round | Funding Date | Pre-Money Valuation | Post-Money Valuation | Amount Raised | Shares Authorized | Issuance Price | Dividend Rate | Liquidation Preferences | Liquidation Price | Participation | Conversion Price | Anti Dilution | General Voting | Board Voting | Par Value |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Series D | |||||||||||||||
Series C | |||||||||||||||
Convertible Note |
Reify Health Investors
11 Investors
Reify Health has 11 investors. Battery Ventures invested in Reify Health's Series D funding round.
First funding | Last Funding | Investor | Rounds | Board Seats | Type | Location |
---|---|---|---|---|---|---|
8/12/2020 | 4/21/2022 | 3 Series B, Series C (2021), Series D (2022) | Venture Capital | Massachusetts | ||
8/10/2021 | 4/21/2022 | 2 Series C, Series D (2022) | Private Equity | Illinois | ||
8/10/2021 | 4/21/2022 | 2 Series C, Series D (2022) | Hedge Fund | New York | ||
Private Equity | California | |||||
Asset/Investment Management | Massachusetts |
First funding | 8/12/2020 | 8/10/2021 | 8/10/2021 | ||
---|---|---|---|---|---|
Last Funding | 4/21/2022 | 4/21/2022 | 4/21/2022 | ||
Investor | |||||
Rounds | 3 Series B, Series C (2021), Series D (2022) | 2 Series C, Series D (2022) | 2 Series C, Series D (2022) | ||
Board Seats | |||||
Type | Venture Capital | Private Equity | Hedge Fund | Private Equity | Asset/Investment Management |
Location | Massachusetts | Illinois | New York | California | Massachusetts |
Compare Reify Health to Competitors
Medable specializes in providing digital clinical trial software solutions within the healthcare and pharmaceutical sectors. The company offers a comprehensive platform that facilitates the management of clinical trials, including tools for remote data collection, electronic consent (eConsent), patient-reported outcomes (ePRO), and clinical outcome assessments (eCOA), all designed to streamline the trial process and enhance data quality. Medable was formerly known as Dermatrap. It was founded in 2012 and is based in Palo Alto, California.
Curebase provides a range of software tools designed for clinical trial recruitment, consent, and data collection processes. Curebase primarily serves the clinical research industry, including CROs, research sites, and study participants. The company was founded in 2017 and is based in San Francisco, California.
THREAD is a company that focuses on providing a decentralized clinical trial platform in the healthcare and life sciences industry. The company offers a platform and supporting services that enable biopharma, CROs, and life science organizations to remotely capture data from participants and sites during, in-between, and in lieu of in-clinic visits. The platform includes features such as electronic consent (eConsent), electronic clinical outcome assessment (eCOA), sensors, reminders, and telehealth virtual visits. It was founded in 2005 and is based in Tustin, California.
Hawthorne Effect specializes in providing mobile, tech-driven solutions for clinical trials within the healthcare sector. The company offers a platform that facilitates mobile clinical trial visits, enhances patient access, and ensures high-quality data collection through a network of healthcare professionals. Hawthorne Effect primarily serves the biopharma, medtech, and healthcare industries by improving clinical trial efficiency, data quality, and patient diversity. It was founded in 2015 and is based in Lafayette, California.
Formation Bio is a tech-driven, AI-native pharmaceutical company focused on drug development. The company specializes in acquiring and developing clinical-stage drugs more efficiently by leveraging a proprietary technology platform that incorporates artificial intelligence. Formation Bio primarily serves the pharmaceutical industry by expediting the drug development process for various therapeutic areas. It was formerly known as TrialSpark. It was founded in 2013 and is based in New York, New York.
BloqCube is a software company specializing in decentralized clinical trial management and financial systems. The company offers an integrated Clinical Trial Management & Financial System (CTMFS) platform designed to accelerate Decentralized Clinical Trials (DCT) by providing a secure, transparent, and efficient way to manage trials and handle financial transactions. BloqCube primarily serves the healthcare and pharmaceutical sectors by streamlining clinical trial processes and financial management. It was founded in 2017 and is based in Piscataway, New Jersey.
Loading...